Project Grant 2434949

Award Date 4/15/25
Completion Date 3/31/27
Dollars Obligated $500K
Federal Grant Program
47.070
Assistance Type
Project Grant
Place of Performance
Ann Arbor, MI 48109, USA
Similar Awards
This National Science Foundation (NSF) Computer and Information Science and Engineering (CISE) Program (CFDA 47.070) project grant award of $1,500,000 to the University of Notre Dame will develop an AI-driven paradigm to promote community resilience for teenagers and young adults (TYAs) against opioid misuse and addiction. The key products and services to be delivered include: Developing graph neural networks and novel self-supervised/prompt learning techniques to detect at-risk TYAs from...
This $903,135 federal Project Grant award from the National Science Foundation's (NSF) Computer and Information Science and Engineering (CISE) program (CFDA 47.070) is supporting the development of an automated pain recognition artificial intelligence (AI)-enabled monitoring system (PRAMS) for newborn babies. The project aims to create a novel hybrid federated learning approach to build an AI model that can accurately detect pain in diverse newborn populations based on facial expressions and...
This federal Project Grant award for $701,959, funded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to improve perioperative care for patients with opioid tolerance. The key objectives are to: Prospectively capture patient-reported opioid use and pain outcomes among opioid tolerant individuals undergoing common surgical procedures, and develop a clinical care pathway to optimize outcomes across a network of hospitals in...
This federal Project Grant award, with a total funding amount of $650,079, was provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) grant program. The award will support research by Northeastern University to develop and optimize novel small-molecule probes targeting the alpha9-nicotinic acetylcholine receptor (α9*-nAChR) as a novel approach for managing chronic...
This National Science Foundation (NSF) Engineering (CFDA 47.041) Project Grant award to Arizona State University (ASU), worth $241,401, aims to develop in vitro models that accurately replicate the peripheral features of chronic pain to enhance understanding of the underlying mechanisms and identify new treatment targets. The project will engineer a physiologically relevant multi-compartment model of nociceptor hypersensitivity and validate its response to noxious stimuli (Objective 1). It...
This $2,314,276 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Drug Use and Addiction Research Programs (CFDA 93.279) supports research at Emory University to develop novel methods for experimentally inducing and measuring nociceptive-specific (pain-specific) responses in humans. The key objectives are to: Identify and utilize naturally occurring skin regions devoid of innocuous warm fibers to selectively stimulate nociceptors and obtain...
This federal Project Grant award of $675,107 from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) supports research to develop non-opioid, non-addictive analgesics for treating neuropathic pain. The primary objectives are to design and synthesize novel cannabinoid receptor ligands that act as both CB1 allosteric agonist-positive allosteric modulators and CB2 agonists. This...
This $2,103,564 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to investigate the role of the nuclear receptor NR4A1 in mediating pain resolution and limiting chronic pain. The award to the University of Cincinnati will fund research across three specific aims: Testing whether NR4A1 in macrophages controls the resolution of inflammation and postoperative pain in mice....
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $397,829 to Callentis Consulting Group LLC to develop an AI platform for discovering new therapeutic treatments for substance use disorders (SUDs). The key products and services to be delivered include: Curated training datasets and machine learning (ML) models to accelerate drug discovery tasks for SUDs. Identification of novel mechanistic targets...
This National Science Foundation (NSF) Computer and Information Science and Engineering (CISE) federal Project Grant award, with CFDA number 47.070, provides $182,477 in funding to Tufts University to develop "decision-aware" machine learning methods that can directly satisfy stakeholder goals in applications such as detecting heart disease and predicting opioid overdoses. The 5-year project, starting on July 1, 2024, will focus on three key technical innovations: 1) decision-aware...

This $499,742 federal Project Grant award from the National Science Foundation (NSF) Computer and Information Science and Engineering (CISE) program (CFDA 47.070) aims to develop a novel AI framework for designing safer, non-addictive pain relief medications. The primary objectives are to create an AI system that generates candidate drug molecules capable of enhancing the body's natural pain control mechanisms, and to establish a transparent machine learning model that can extract hidden scientific rules and constraints to improve the reliability of the AI-generated solutions. The award recipient, the Regents of the University of Michigan, will carry out the key research activities, which include developing a generative AI system using conditional variational autoencoders with grammar-based and physics-informed constraints, as well as designing a reinforcement learning-based transparent machine learning model to uncover unknown scientific constraints. This project seeks to address the urgent public health challenge of the opioid crisis by leveraging advanced AI techniques to revolutionize the drug design process and produce effective pain relief medications without the risk of addiction.

Generated 4/29/25, 4:16 AM